GlassScriptPhysician profile
Joshua D Moss
NPI 1235129073
$138,207.47
in general payments reported to CMS, 2019-2025
15 companies · $22K in 2025
The $22K reported for 2025 was more than what 90% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $7,497 · 2021: $14K · 2022: $15K · 2023: $35K · 2024: $20K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Travel and Lodging: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,945 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,000 · Food and Beverage: $5,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,059.88 |
| Travel and Lodging | $21,973.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,945.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,000.00 |
| Food and Beverage | $5,548.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $72,521.61 | 2019-2025 | Ensite Precision, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $26,996.62 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Nuvision Ice Catheter |
| Medical Device Business Services, INC. | $23,570.03 | 2019-2025 | Carto 3 |
| Boston Scientific Corporation | $5,289.86 | 2022-2025 | Accolade Sr, Farapulse |
| Cardiva Medical, INC. | $4,171.56 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biotronik INC. | $2,687.97 | 2019-2025 | |
| Itamar Medical INC | $1,118.44 | 2021-2022 | |
| Acutus Medical, INC. | $775.17 | 2019 | |
| Medtronic, INC. | $568.98 | 2023-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Ebr Systems, INC. | $199.14 | 2025 | |
| Abiomed | $127.51 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $99.74 | 2019 | |
| Medtronic Vascular, INC. | $34.99 | 2020 | |
| Allergan, INC. | $24.87 | 2019 | |
| Impulse Dynamics (USA) INC. | $20.98 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.